Deviation Management and CAPA
Prague, Czech Republic
Course No 17872
You can find all other dates of this seminar in this overview.
Our Service
Costs
| ECA-Member: | EUR 1490,-- |
| Non ECA Member: | EUR 1690,-- |
| EU/GMP Inspectorates: | EUR 845,-- |
| APIC Member Discount: | EUR 1590,-- |
(All prices excl. VAT)
If you have any questions, please contact us:
Tel.: +49 (0)6221 / 84 44 0 E-Mail: info@gmp-compliance.org
Speakers
Dr Martin M. Appel, Switzerland
Marcus Heinbuch, B.Braun Melsungen AG, Germany
Dr Ulrich Herber, Charles River, Ireland
Mick Hopper, GxPpro, U.K.
Lea Joos, GMP/GDP Inspectorate, Germany
Marcus Heinbuch, B.Braun Melsungen AG, Germany
Dr Ulrich Herber, Charles River, Ireland
Mick Hopper, GxPpro, U.K.
Lea Joos, GMP/GDP Inspectorate, Germany
Objectives
During this course, you will get to know the principles and discuss all relevant aspects to implement, improve and/ or work with a Deviation Management and CAPA System. Furthermore, you will get to know possibilities and tools to monitor and evaluate your CAPAs.
Background
Things will go wrong from time to time. In the world of pharmaceuticals, we need to ensure that we have robust processes and procedures in place to deal with such situations. When an unplanned event arises it must be handled accordingly.
FDA’s Quality System Guide, recent Warning Letters and EU-GMP Chapter 1 clearly emphasise the increasing relevance of a proper deviation management and CAPAs. ICH Q9 on Quality Risk Management and ICH Q10 on Pharmaceutical Quality Systems empower us to handle issues that arise in our daily work on the basis of risk analysis.
In any case a sound failure investigation is the key to identify appropriate CAPAs. Here it is also important to know how to deal with human error based and non-human error based non-conformances.
Independent from that, it needs to be pointed out that CAPA is an excellent Quality Management tool to continuously improve processes and avoid future failures. All personnel involved in the management of deviations and CAPAs should aim to identify opportunities for further improvement.
FDA’s Quality System Guide, recent Warning Letters and EU-GMP Chapter 1 clearly emphasise the increasing relevance of a proper deviation management and CAPAs. ICH Q9 on Quality Risk Management and ICH Q10 on Pharmaceutical Quality Systems empower us to handle issues that arise in our daily work on the basis of risk analysis.
In any case a sound failure investigation is the key to identify appropriate CAPAs. Here it is also important to know how to deal with human error based and non-human error based non-conformances.
Independent from that, it needs to be pointed out that CAPA is an excellent Quality Management tool to continuously improve processes and avoid future failures. All personnel involved in the management of deviations and CAPAs should aim to identify opportunities for further improvement.
Target Group
This course is designed for all personnel involved in Deviation Management and CAPA activities at their company. It is addressed to persons from Quality Assurance and Control, Manufacturing and R&D.
Programme
International Requirements – Rules and Regulations
- European requirements
- The expectations of the FDA
- GMP and documentation issues
- Harmonisation in sight?
Deviation Handling
- How to document deviations
- Information and Data Management
- Critical/ major/ minor
- CAPA or not?
CAPA: Principles, System, Implementation and Process Improvements and the use of Risk Management Techniques
- Tools
- Quality Risk Management
- Human Error Overview
- Monitoring & Evaluation Overview
Workshop: An interactive exercise on scenarios with a focus on using the tools from the presentation
- Human Error based
- Non-human error based
Deviations in the Light of Inspections
- Focus in inspection
- Trends, Product Quality Review and Product Review
- Self-inspection as an important tool
Case Study: How to implement a CAPA System
- How to integrate existing QM Systems (OOS, Complaint Handling, Deviations)
- Examples and lessons learned
Case Study: How to deal with microbiological Deviations
- Contamination control and company culture
- What QA needs to understand
- Interface with QA and production
- OOS vs. deviation in the microbiological laboratory
- Possible CAPAs
Case Study: Implementation of a Software Tool for CAPA Management
- Understanding your workflows and processes
- Can you improve the current process using electronic workflows?
- Efficient validation of a CAPA application
CAPA Effectiveness & System Performance Check
As part of the periodic quality review programme, Quality Management should routinely analyse reports of deviations and CAPAs to determine KPIs, trends, recurrence of non-conformances and effectiveness of CAPAs.
A summary overview should be reported to the Senior Management team. ICH Q10 identifies this as best practice - but are we doing this as well as we could or should?
We will discuss Quality Metrics as well as which are the important ones that will show you have a good Pharmaceutical Quality System.
Workshop on CAPA Effectiveness & System Performance Check
An interactive session with a focus on enhancing the knowledge gained in the presentation.
A summary overview should be reported to the Senior Management team. ICH Q10 identifies this as best practice - but are we doing this as well as we could or should?
We will discuss Quality Metrics as well as which are the important ones that will show you have a good Pharmaceutical Quality System.
Workshop on CAPA Effectiveness & System Performance Check
An interactive session with a focus on enhancing the knowledge gained in the presentation.
GMP Conferences by Topics
- Quality Assurance
- GMP in Biotechnology
- Microbiology
- Regulatory Affairs
- GMP in Pharmaceutical Development
- Quality Control
- GDP
- Sterile / Aseptic Manufacturing
- Computer Validation
- Validation
- Technical Operations
- GMP for APIs and Excipients
- Medical Devices
- GMP Basic Training Courses
- Packaging
- Data Integrity